A detailed history of Lincoln Capital Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Lincoln Capital Corp holds 349 shares of LLY stock, worth $275,078. This represents 0.13% of its overall portfolio holdings.

Number of Shares
349
Previous 339 2.95%
Holding current value
$275,078
Previous $306,000 0.98%
% of portfolio
0.13%
Previous 0.13%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$772.14 - $960.02 $7,721 - $9,600
10 Added 2.95%
349 $309,000
Q2 2024

Jul 23, 2024

BUY
$724.87 - $909.04 $724 - $909
1 Added 0.3%
339 $306,000
Q1 2024

Apr 15, 2024

BUY
$592.2 - $792.28 $200,163 - $267,790
338 New
338 $262,000
Q2 2018

Jul 26, 2018

SELL
$75.7 - $86.88 $1.25 Million - $1.43 Million
-16,489 Closed
0 $0
Q1 2018

Apr 12, 2018

SELL
$74.21 - $87.6 $153,392 - $181,069
-2,067 Reduced 11.14%
16,489 $1.28 Million
Q4 2017

Feb 06, 2018

BUY
$81.94 - $87.89 $1.52 Million - $1.63 Million
18,556
18,556 $1.57 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Lincoln Capital Corp Portfolio

Follow Lincoln Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lincoln Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lincoln Capital Corp with notifications on news.